The impact of the Cancer Genome Atlas on lung cancer

被引:92
作者
Chang, Jeremy T. -H.
Lee, Yee Ming
Huang, R. Stephanie
机构
[1] Univ Chicago, Biol Sci Collegiate Div, Chicago, IL 60637 USA
[2] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Med, Chicago, IL 60637 USA
关键词
MESSENGER-RNA; COPY NUMBER; TRANSCRIPTIONAL REGULATION; 1ST-LINE TREATMENT; TUMOR-SUPPRESSOR; OPEN-LABEL; EXPRESSION; GENE; CHEMOTHERAPY; MUTATION;
D O I
10.1016/j.trsl.2015.08.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The Cancer Genome Atlas (TCGA) has profiled more than 10,000 samples derived from 33 types of cancer to date, with the goal of improving our understanding of the molecular basis of cancer and advancing our ability to diagnose, treat, and prevent cancer. This review focuses on lung cancer as it is the leading cause of cancer-related mortality worldwide in both men and women. Particularly, non-small cell lung cancers (including lung adenocarcinoma and lung squamous cell carcinoma) were evaluated. Our goal was to demonstrate the impact of TCGA on lung cancer research under 4 themes: diagnostic markers, disease progression markers, novel therapeutic targets, and novel tools. Examples are given related to DNA mutation, copy number variation, messenger RNA, and microRNA expression along with methylation profiling.
引用
收藏
页码:568 / 585
页数:18
相关论文
共 105 条
[1]   The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology [J].
Abaan, Ogan D. ;
Polley, Eric C. ;
Davis, Sean R. ;
Zhu, Yuelin J. ;
Bilke, Sven ;
Walker, Robert L. ;
Pineda, Marbin ;
Gindin, Yevgeniy ;
Jiang, Yuan ;
Reinhold, William C. ;
Holbeck, Susan L. ;
Simon, Richard M. ;
Doroshow, James H. ;
Pommier, Yves ;
Meltzer, Paul S. .
CANCER RESEARCH, 2013, 73 (14) :4372-4382
[2]   PIAS3 expression in squamous cell lung cancer is low and predicts overall survival [J].
Abbas, Rime ;
McColl, Karen S. ;
Kresak, Adam ;
Yang, Michael ;
Chen, Yanwen ;
Fu, Pingfu ;
Wildey, Gary ;
Dowlati, Afshin .
CANCER MEDICINE, 2015, 4 (03) :325-332
[3]   EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation [J].
Antonicelli, Alberto ;
Cafarotti, Stefano ;
Indini, Alice ;
Galli, Alessio ;
Russo, Andrea ;
Cesario, Alfredo ;
Lococo, Filippo Maria ;
Russo, Patrizia ;
Mainini, Alberto Franco ;
Bonifati, Luca Giuseppe ;
Nosotti, Mario ;
Santambrogio, Luigi ;
Margaritora, Stefano ;
Granone, Pierluigi Maria ;
Dutly, Andre Emanuel .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (03) :320-330
[4]   Intra-Tumour Signalling Entropy Determines Clinical Outcome in Breast and Lung Cancer [J].
Banerji, Christopher R. S. ;
Severini, Simone ;
Caldas, Carlos ;
Teschendorff, Andrew E. .
PLOS COMPUTATIONAL BIOLOGY, 2015, 11 (03)
[5]   Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes [J].
Biankin, Andrew V. ;
Waddell, Nicola ;
Kassahn, Karin S. ;
Gingras, Marie-Claude ;
Muthuswamy, Lakshmi B. ;
Johns, Amber L. ;
Miller, David K. ;
Wilson, Peter J. ;
Patch, Ann-Marie ;
Wu, Jianmin ;
Chang, David K. ;
Cowley, Mark J. ;
Gardiner, Brooke B. ;
Song, Sarah ;
Harliwong, Ivon ;
Idrisoglu, Senel ;
Nourse, Craig ;
Nourbakhsh, Ehsan ;
Manning, Suzanne ;
Wani, Shivangi ;
Gongora, Milena ;
Pajic, Marina ;
Scarlett, Christopher J. ;
Gill, Anthony J. ;
Pinho, Andreia V. ;
Rooman, Ilse ;
Anderson, Matthew ;
Holmes, Oliver ;
Leonard, Conrad ;
Taylor, Darrin ;
Wood, Scott ;
Xu, Qinying ;
Nones, Katia ;
Fink, J. Lynn ;
Christ, Angelika ;
Bruxner, Tim ;
Cloonan, Nicole ;
Kolle, Gabriel ;
Newell, Felicity ;
Pinese, Mark ;
Mead, R. Scott ;
Humphris, Jeremy L. ;
Kaplan, Warren ;
Jones, Marc D. ;
Colvin, Emily K. ;
Nagrial, Adnan M. ;
Humphrey, Emily S. ;
Chou, Angela ;
Chin, Venessa T. ;
Chantrill, Lorraine A. .
NATURE, 2012, 491 (7424) :399-405
[6]   Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: Implications for STAT-3 activation and gene expression [J].
Brantley, Emily C. ;
Nabors, L. Burton ;
Gillespie, G. Yancey ;
Choi, Youn-Hee ;
Palmer, Cheryl Ann ;
Harrison, Keith ;
Roarty, Kevin ;
Benveniste, Etty N. .
CLINICAL CANCER RESEARCH, 2008, 14 (15) :4694-4704
[7]   The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis [J].
Brennan, Sarah E. ;
Kuwano, Yuki ;
Alkharouf, Nadim ;
Blackshear, Perry J. ;
Gorospe, Myriam ;
Wilson, Gerald M. .
CANCER RESEARCH, 2009, 69 (12) :5168-5176
[8]   Tristetraprolin (TTP): Interactions with mRNA and proteins, and current thoughts on mechanisms of action [J].
Brooks, Seth A. ;
Blackshear, Perry J. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2013, 1829 (6-7) :666-679
[9]   p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-Neu oncogene-dependent breast tumorigenesis [J].
Cabodi, Sara ;
Tinnirello, Agata ;
Di Stefano, Paola ;
Bisaro, Brigitte ;
Ambrosino, Elena ;
Castellano, Isabella ;
Sapino, Anna ;
Arisio, Riccardo ;
Cavallo, Federica ;
Forni, Guido ;
Glukhova, Marina ;
Silengo, Lorenzo ;
Altruda, Fiorella ;
Turco, Emilia ;
Tarone, Guido ;
Defilippi, Paola .
CANCER RESEARCH, 2006, 66 (09) :4672-4680
[10]   p130Cas is an essential transducer element in ErbB2 transformation [J].
Cabodi, Sara ;
Tinnirello, Agata ;
Bisaro, Brigitte ;
Tornillo, Giusy ;
Camacho-Leal, Maria del Pilar ;
Forni, Guido ;
Cojoca, Rodica ;
Iezzi, Manuela ;
Amici, Augusto ;
Montani, Maura ;
Eva, Alessandra ;
Di Stefano, Paola ;
Muthuswamy, Senthil K. ;
Tarone, Guido ;
Turco, Emilia ;
Defilippi, Paola .
FASEB JOURNAL, 2010, 24 (10) :3796-3808